MDHearing Volt vs Vivtone Xpure Hearing Aid

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.

The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.